Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Cosenza
Clinical trial register · Italy

Clinical Trials in Cosenza, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Cosenza

24 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Chieti, Bari, Castellana Grotte (BA), Catanzaro, Cosenza, Naples, Salerno, Ferrara
2026-10-26
Recruiting
AstraZeneca
Phase 3
2,800
Bari, Bologna, Cosenza, Cremona, Genoa, Milan, Modena, Naples
2026-09-01
Not yet open
Spinery Basivertebral Nerve Ablation for Vertebrogenic Chronic Low Back Pain
NCT07696507Low Back Pain, Chronic Low Back Pain (CLBP)
Axon srl
Not applicable
69
Cagliari, Cosenza, Naples
2026-09
Recruiting
AstraZeneca
Phase 3
7,000
Alessandria, Bari, Bologna, Catania, Chieri, Cinisello Balsamo, Cosenza, Eboli
2026-08-21
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Chieti, Cosenza, Naples, Bentivoglio, Bologna, Ferrara, Reggio Emilia, Udine
2026-05-11
Recruiting
RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
NCT07541521Stage IIB-III NSCLC, Sleeve Lobectomy, Robotic Surgery, Neoadjuvant Chemoimmunotherapy
Shanghai Chest Hospital
Observational
100
Cosenza
2026-04-13
Recruiting
Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
NCT07528066Neoadjuvant Chemoimmunotherapy, Robotic Pulmonary Resection, Stage IIB-III NSCLC
Shanghai Chest Hospital
Observational
200
Cosenza
2026-03-02
Recruiting
Sepsis and Hospital Mortality
NCT07022041Sepsis
University of Calabria
Observational
100
Cosenza
2025-07-15
Recruiting
University of Calabria
Observational
100
Cosenza
2025-07-01
Recruiting
Prognostic Role of AI-Echo
NCT07009639Atrial Cardiomyopathy
University of Calabria
Observational
45
Cosenza
2025-07-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
59
Alessandria, Bologna, Catania, Cosenza, Ferrara, Meldola, Milan, Padova
2024-12-09
Recruiting
Istituto Nazionale di Ricovero e Cura per Anziani
Observational
374
Ancona, Cosenza
2024-06-20
Active, closed
University Hospital of Ferrara
Not applicable
1,823
Bologna, Ferrara, Bolzano, Catanzaro, Cosenza, Baggiovara, Piacenza, Parma
2023-05-08
Active, closed
Novartis Pharmaceuticals
Observational
242
Alessandria, Ancona, Bari, Bologna, Como, Cosenza, Catania, Florence
2023-03-02
Recruiting
Associazione Qol-one
Phase 2
22
Alessandria, Ancona, Avellino, Biella, Catania, Chivasso, Cosenza, Florence
2022-11-03
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Alessandria, Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Cosenza
2022-09-08
Recruiting
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
1,000
Legnano, Orbassano, Ancona, Bari, Bergamo, Brescia, Cagliari, Cosenza
2022-07-13
Recruiting
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
NCT06516406Myelofibrosis, Primary Myelofibrosis, Secondary Myelofibrosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,055
Cosenza, Reggio Calabria, Naples, Bologna, Ferrara, Parma, Piacenza, Ravenna
2022-05-06
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
800
Chieti, Potenza, Caserta, Catanzaro, Cosenza, Bologna, Genova, Bergamo
2022-01-26
Active, closed
Medtronic
Observational
2,200
Bologna, Cosenza, Lecce, Milan, Taranto, Udine
2020-08-01
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
321
Cona, Alessandria, Bari, Cagliari, Catania, Catanzaro, Cosenza, Florence
2020-07-24
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
530
Ancona, Bologna, Brindisi, Cagliari, Catania, Catanzaro, Cona, Cosenza
2017-11-13
Active, closed
Endurant CHevAr New Indication Trial: ENCHANT
NCT03320252AAA - Abdominal Aortic Aneurysm
Medtronic Cardiovascular
Observational
150
Cosenza, La Spezia, Roma
2017-10-26
Active, closed
Associazione Qol-one
Phase 2
174
Alessandria, Ancona, Asti, Avellino, Bari, Brindisi, Cagliari, Cosenza
2011-06-11
Rows per page Showing 1–24 of 24
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/cosenza

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 24 of those studies with a site in Cosenza.

How many clinical trials are recruiting in Cosenza?

15 of the 24 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cosenza), 24 studies
PhaseStudiesRecruitingShare
Observational151062.5%
Phase 35420.8%
Not applicable208.3%
Phase 2218.3%

Most active sponsors

Lead sponsors with the most studies (Cosenza)
Lead sponsorStudiesRecruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna33
University of Calabria33
Associazione Qol-one21
AstraZeneca22
Gruppo Italiano Malattie EMatologiche dell'Adulto20
Novo Nordisk A/S21
Shanghai Chest Hospital22
Axon srl10
European Myeloma Network B.V.11
Fondazione IRCCS Policlinico San Matteo di Pavia11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.